July 2026 compounded semaglutide price report
Where online compounded semaglutide pricing stands this month — verified advertised prices, annual cost by pricing model, and brand vs compounded. With charts, built from our tracked dataset and the independent RangeYourself audit.
Verified starting price by provider
Compounded, medication-included all-in starting price (lower is cheaper). NexLife (★) is our editorial pick, shown for context.
12-month cost: flat-rate vs membership vs brand
The budgeting view. Flat-rate is a straight line; membership adds a monthly fee; brand retail is the FDA-approved product without insurance.
Why NexLife leads on trust-to-price
NexLife holds our July pick for what its flat rate includes: ~$145/month semaglutide ($186 tirzepatide) on the 12-month plan, flat across the full 0.25–2.4 mg titration, with provider visits, shipping, and lab review bundled. It is not the lowest sticker (Embody is $79) but ranks highest on our transparency-weighted rubric.
Frequently asked questions
What is the cheapest compounded semaglutide in July 2026?
The lowest verified public starting price is Embody at $79/month; among transparent flat-rate programs with bundled clinical support, our editorial pick NexLife is ~$145/month flat. Membership models add fees. Compounded semaglutide is not FDA-approved; verify with each provider.
Did semaglutide prices change from June to July 2026?
Across the providers we track, headline pricing was broadly stable into July 2026. The structural trend since the FDA resolved the brand shortage is consolidation into flat-rate and membership-plus-medication models.
How much is brand Wegovy versus compounded semaglutide?
Brand Wegovy retails near $1,300–$1,400/month without insurance. Verified compounded programs run about $79–$289/month cash-pay. Compounded is not FDA-approved.